In a recent study, Cytel researchers discussed the benefits of Bayesian models. They’re a good choice for both single arm and randomized clinical trials where control data must be integrated into the dataset. However, despite being developed before Frequentist models, they have not been widely used in clinical research.
Cytel consultant Pantelis Vlachos claims “The array of Bayesian methods is vast, and with computing power now more easily accessible to a wide range of statisticians, these methods are perpetuating the trial design space.” Click here to learn more.
(Source: Pantelis Vlachos, Cytel, 1/26/21)
